ArticleCancer letters2019

BET protein targeting suppresses the PD-1/PD-L1 pathway in triple-negative breast cancer and elicits anti-tumor immune response.

Guillaume P Andrieu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.